Guy Levy, Director at BioAtla, Inc. (BCAB), sold 800,000 shares at $39.16 ($31.3M) on 2021-06-17, disclosed to the SEC on 2021-06-21.
Open-market sale of $31.3M BCAB by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.16 | 62,780 | $2.5M | 7.8% |
| 2 | $39.16 | 62,780 | $2.5M | 7.8% |
| 3 | $39.16 | 337,220 | $13.2M | 42.2% |
| 4 | $39.16 | 337,220 | $13.2M | 42.2% |
| Total | $39.16 avg | 800,000 | $31.3M | 100% |
| Filing → |
| BCAB | BUY | 2020-12-22 | $25.0M | — | Filing → |